These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11923824

  • 1. Japanese rules hinder commercialization of publicly funded projects.
    Triendl R.
    Nat Biotechnol; 2002 Apr; 20(4):325. PubMed ID: 11923824
    [No Abstract] [Full Text] [Related]

  • 2. Surprise US election results may boost biotech.
    Fox JL.
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract] [Full Text] [Related]

  • 3. OECD guidelines on open access: commercialization in disguise?
    Hoeyer K, Svendsen MN, Koch L.
    Trends Biotechnol; 2008 Sep; 26(9):479-82. PubMed ID: 18684538
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Startups hope federal study fixes SBIR flaws.
    Basu P.
    Nat Biotechnol; 2004 Jun; 22(6):644. PubMed ID: 15175671
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Japanese council urges reform of funding system.
    Triendl R.
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effectiveness casts first shadows across US industry.
    Waltz E.
    Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
    [No Abstract] [Full Text] [Related]

  • 11. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J, Enzing C, Joly PB, Reiss T.
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract] [Full Text] [Related]

  • 12. Impact of the "new science" of genomics.
    Coile RC.
    J Healthc Manag; 2001 Jun; 46(6):365-8. PubMed ID: 11729566
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surreal US budget again favors R&D spending.
    Fox JL.
    Nat Biotechnol; 1996 May; 14(5):562-3. PubMed ID: 9630937
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Japan banks on budget to boost biotechnology.
    Saegusa A.
    Nat Biotechnol; 2000 Feb; 18(2):142. PubMed ID: 10657110
    [No Abstract] [Full Text] [Related]

  • 17. Legal row looms for gene-map firm.
    Dalton R.
    Nature; 2003 May 29; 423(6939):470. PubMed ID: 12774085
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nuclear safety and biotech boosted in Japan's budget.
    Saegusa A.
    Nature; 1999 Dec 02; 402(6761):451. PubMed ID: 10591194
    [No Abstract] [Full Text] [Related]

  • 20. Genomics boosted as Japan unveils plans for state-funded companies.
    Barker S.
    Nature; 1995 Nov 02; 378(6552):2. PubMed ID: 7477278
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.